NCT06896123

Brief Summary

A new and in-teresting complementary approach for rehabilitation of parkinsonian patients is represented by "Dance Well", which is an artistic, multisensory dance intervention based on art and music. This study aims to evaluate the efficacy, feasibility, and safety of a 4-week Dance Well (DW) program in PD patients in early-medium disease stages.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 7, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

March 10, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 26, 2025

Completed
Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

5 months

First QC Date

March 10, 2025

Last Update Submit

March 25, 2025

Conditions

Keywords

PDDance WellRehabilitation Therapy

Outcome Measures

Primary Outcomes (1)

  • UPDRS III

    UPDRS III (Unified Parkinson's Disease Rating Scale, Part III) is a clinical tool used to assess motor function in Parkinson's disease patients. It evaluates symptoms such as tremors, rigidity, bradykinesia, postural stability, gait, and rapid alternating movements. Each item is scored from 0 (no impairment) to 4 (severe impairment), with the total score indicating the overall severity of motor symptoms.

    Form the enrollment to the end of treatment at 4 weeks

Secondary Outcomes (8)

  • Berg Balance Scale (BBS)

    Form the enrollment to the end of treatment at 4 weeks

  • 6-Minute Walk Test (6MWT)

    Form the enrollment to the end of treatment at 4 weeks

  • Timed Up and Go (TUG) Test

    Form the enrollment to the end of treatment at 4 weeks

  • Corsi Supra-Span Block Tapping Test

    Form the enrollment to the end of treatment at 4 weeks

  • Trail Making Test (TMT) A and B-A

    Form the enrollment to the end of treatment at 4 weeks

  • +3 more secondary outcomes

Study Arms (2)

DanceWell Group

EXPERIMENTAL

12 PD patients underwent 4-week Dance Well Program

Behavioral: Dance Well: an artistic, multisensory dance intervention based on art and music

Conventional Therapy Group

ACTIVE COMPARATOR

12 PD patients underwent 4-week Conventional Therapy Program

Behavioral: Conventional motor therapy group

Interventions

DW is specifically designed for people with early to mild severe PD and aims to de-liver multiple stimuli, including rhythmical auditory cues, proprioceptive and sensorimo-tor stimulation, balance training, and aerobic exercise, using carefully selected music to cue movement and promote relaxation. The components of DW are relatively simple and easy to be learned and performed for people with compromised mobility. The intervention is also enjoyable and engaging, as reported for other genres of dance

DanceWell Group

Conventional Motor Therapy consisted on 60-minute conventional physiotherapy, twice a week, for four weeks

Conventional Therapy Group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of PD according to the UK Parkinson's Disease Society Brain Bank clinical diagnostic criteria; rate score 0-3 on the modified Hoehn \& Yahr (H\&Y) scale.

You may not qualify if:

  • other neurological or psychiatric diseases other than PD;
  • serious visual and/or auditory deficits;
  • orthopedic-muscular and or co-morbid medical conditions precluding partici-pation in dance;
  • cognitive decline (MoCA score \< 13,8)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fresco Parkinson Center - Villa Margherita (KOS group)

Arcugnago, VI, 36057, Italy

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
President of KOS Medical Group

Study Record Dates

First Submitted

March 10, 2025

First Posted

March 26, 2025

Study Start

January 7, 2022

Primary Completion

May 31, 2022

Study Completion

September 30, 2022

Last Updated

March 26, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

We do not plan to share individual participant data (IPD) due to concerns related to patient privacy and data security. Ensuring the confidentiality and protection of our participants' personal information is a top priority. Additionally, the resources required to anonymize and manage data sharing securely are not available for this study

Locations